Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sugen LLC

Latest From Sugen LLC

AstraZeneca Pulls Plug On Lumoxiti Due To Low Uptake

Signs of trouble were already emerging in 2020 when Innate backed out of a co-commercialization pact. AstraZeneca plans to discontinue the hairy cell leukemia ADC in July.

Business Strategies Cancer

Sanofi Gains New Innate Program In Expanded Collaboration

Deal Snapshot: Innate will receive 25m up front from Sanofi for an exclusive license to a new natural killer (NK) cell engager program and options to two additional targets.

Deals Cancer

Big Pharma Rescripts India Playbook

Big pharma appears to be resetting operations in India fueling some concerns of waning interest. In Vivo looks at what the realignment means or doesn’t.

Outlook 2023 Strategy

Dissecting Piramal’s Damages Award In Sensipar Case

A legal expert details how Piramal Healthcare could turn the tables and secure damages in the litigation pertaining to its generic version of Amgen's Sensipar, a case which saw multiple at-risk launches.

Legal Issues Generic Drugs
See All

Company Information

UsernamePublicRestriction

Register